The Food and Drug Administration’s recent decision to approve a new generic abortion pill has elicited strong backlash from conservative groups. Their anger reflects broader tensions over the future of medication abortion and access to reproductive health care.

The Supreme Court has turned down Planned Parenthood’s attempt to remain a part of a red state’s Medicaid program, marking a significant setback for the reproductive health organization.